Literature DB >> 9522799

Interpreting treatment effects in randomised trials.

G H Guyatt1, E F Juniper, S D Walter, L E Griffith, R S Goldstein.   

Abstract

Mesh：

Year:  1998        PMID： 9522799      PMCID： PMC1112685          DOI： 10.1136/bmj.316.7132.690

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  13 in total

1.  Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.

Authors:  E F Juniper; G H Guyatt; R S Epstein; P J Ferrie; R Jaeschke; T K Hiller
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

2.  Measuring quality of life in children with asthma.

Authors:  E F Juniper; G H Guyatt; D H Feeny; P J Ferrie; L E Griffith; M Townsend
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

3.  Basic statistics for clinicians: 3. Assessing the effects of treatment: measures of association.

Authors:  R Jaeschke; G Guyatt; H Shannon; S Walter; D Cook; N Heddle
Journal:  CMAJ       Date:  1995-02-01       Impact factor: 8.262

4.  Measurement of health status. Ascertaining the minimal clinically important difference.

Authors:  R Jaeschke; J Singer; G H Guyatt
Journal:  Control Clin Trials       Date:  1989-12

5.  An assessment of clinically useful measures of the consequences of treatment.

Authors:  A Laupacis; D L Sackett; R S Roberts
Journal:  N Engl J Med       Date:  1988-06-30       Impact factor: 91.245

6.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

Authors:  E F Juniper; G H Guyatt; A Willan; L E Griffith
Journal:  J Clin Epidemiol       Date:  1994-01       Impact factor: 6.437

7.  Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.

Authors:  E F Juniper; P R Johnston; C M Borkhoff; G H Guyatt; L P Boulet; A Haukioja
Journal:  Am J Respir Crit Care Med       Date:  1995-01       Impact factor: 21.405

8.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

9.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

10.  Randomised controlled trial of respiratory rehabilitation.

Authors:  R S Goldstein; E H Gort; D Stubbing; M A Avendano; G H Guyatt
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321
View more
  115 in total

1.  Using the standard error of measurement to identify important changes on the Asthma Quality of Life Questionnaire.

Authors:  Kathleen W Wyrwich; William M Tierney; Fredric D Wolinsky
Journal:  Qual Life Res       Date:  2002-02       Impact factor: 4.147

Review 2.  Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II.

Authors:  G Samsa; D Edelman; M L Rothman; G R Williams; J Lipscomb; D Matchar
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

3.  Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma.

Authors:  D Brocklebank; J Wright; C Cates
Journal:  BMJ       Date:  2001-10-20

4.  Corticosteroid injections for osteoarthritis of the knee: meta-analysis.

Authors:  Bruce Arroll; Felicity Goodyear-Smith
Journal:  BMJ       Date:  2004-03-23

5.  Health-related quality of life as an outcome variable in Parkinson's disease.

Authors:  Pablo Martinez-Martin; Mónica M Kurtis
Journal:  Ther Adv Neurol Disord       Date:  2012-03       Impact factor: 6.570

6.  Outcomes in cardiopulmonary physical therapy: sickness impact profile.

Authors:  Sheronda Bowers; Katie Cannizzaro; Jessica Gregus; Quanteria Scott; Jane Eason
Journal:  Cardiopulm Phys Ther J       Date:  2009-03

7.  Angiotensin-converting enzyme inhibitor use by older adults is associated with greater functional responses to exercise.

Authors:  Thomas W Buford; Todd M Manini; Fang-Chi Hsu; Matteo Cesari; Stephen D Anton; Susan Nayfield; Randall S Stafford; Timothy S Church; Marco Pahor; Christy S Carter
Journal:  J Am Geriatr Soc       Date:  2012-06-21       Impact factor: 5.562

Review 8.  Toward exercise as personalized medicine.

Authors:  Thomas W Buford; Michael D Roberts; Timothy S Church
Journal:  Sports Med       Date:  2013-03       Impact factor: 11.136

9.  Evaluating minimal clinically important differences for the acne-specific quality of life questionnaire.

Authors:  Lori D McLeod; Sheri E Fehnel; Jane Brandman; Tara Symonds
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

10.  Clinically important change in quality of life in epilepsy.

Authors:  S Wiebe; S Matijevic; M Eliasziw; P A Derry
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-08       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.